Direxion Daily S&P Biotech Bull 3X Shares LABU
241.75 USD +5.43 (+2.30%)
At closeNov 11, 2026, 7:36 PM EST
239.89 -1.86 -0.77%
After hours · Nov 11, 7:36 PM ET
234.60 Day range 244.32
126.79 52-week range 341.55
- YTD
- +51.67%
- 1 year
- +80.09%
News
247wallst.com Why $55 Million Flowed Into a Triple-Leveraged Biotech ETF Worth Less Than $600 Million Traders poured tens of millions into a triple-leveraged biotech fund in a single day, a move that looks like bold conviction until you see what that same bet returned over five years.
etftrends.com Biotech's Rebound Reality: Surging M&A Deals Meet Deep Retail Skepticism Biotechnology stocks are showing signs of a renewed recovery, supported by a pickup in pharmaceutical mergers and acquisitions and investor interest in drug development pipelines. Key Takeaways: Big…
247wallst.com LABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited Breakout If you bought XBI a year ago and held it, you are up roughly 65%. If you bought Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA:LABU) on the same day, you are up about 235%.
247wallst.com Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now Biotech has reasserted itself over the past year as drug approvals,
defenseworld.net 34,270 Shares in Direxion Daily S&P Biotech Bull 3x Shares $LABU Purchased by JPMorgan Chase & Co. JPMorgan Chase and Co. purchased a new stake in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) in the third quarter, according to its most recent Form 13F filing with the Securities and…
defenseworld.net Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Shares Gap Down – Here’s Why Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU - Get Free Report) gapped down prior to trading on Friday. The stock had previously closed at $170.74, but opened at $164.08. Direxion Daily…
247wallst.com Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026 Triple-leveraged ETFs aren't for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull 3X Shares (NASDAQ:LABU) offers the most aggressive way to capture that…
defenseworld.net Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Hits New 1-Year High – What’s Next? Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Thursday. The company traded as high as $186.25 and last…
benzinga.com Navigate Biotech's Crosscurrents With Direxion's LABU And LABD ETFs Although the equities market often embodies chaos and capricious non-linearity, few sectors witness as much kinetic wildness like biotechnology. At its core, biotech represents an innovative push…
defenseworld.net Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Reaches New 52-Week High – What’s Next? Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU - Get Free Report) shares hit a new 52-week high during mid-day trading on Friday. The company traded as high as $169.50 and last traded at…
etftrends.com Top Performing Leveraged/Inverse ETFs: 11/16/2025 Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
etftrends.com New FDA Director Could Sway Biotech ETFs Biotech stocks could sway toward the upside with the appointment of a new director at the Federal Drug Administration's Center for Drug Evaluation and Research. Dr. Richard Pazdur will take the…
seekingalpha.com Follow Signals, Don't Chase Price - JD Henning JD Henning, who runs Value and Momentum Breakouts, shares why following market signals is so important. Leveraging quantitative signals and sector rotation for strong returns.
etftrends.com As M&A Deals Rise, Can Biotech Pharma Break Loose? After a relatively sluggish 2024 for mergers & acquisitions (M&A) activity in the biopharma sector, the environment could be more conducive for deals in the rest of 2025. The industry, like the rest…
etftrends.com Top Performing Leveraged/Inverse ETFs: 09/07/2025 Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
etftrends.com Top Performing Leveraged/Inverse ETFs: 08/17/2025 Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
etftrends.com Top Performing Leveraged/Inverse ETFs: 04/20/2025 Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
etftrends.com Rising Number of Flu Cases Could Elevate These ETFs Cases of the flu have reached elevated levels as of late. This could keep healthcare stocks and ETFs with a healthcare focus on the radar for traders.
etftrends.com Top Performing Leveraged/Inverse ETFs: 01/26/2025 Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
etftrends.com There Could Be Value in Healthcare Stocks Ahead of 2025 When a new presidential administration is set to take office, there's uncertainty as to whether specific sectors could be impacted. In the case of healthcare, that's certainly the case, especially in…
benzinga.com EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks Direxion's Ed Egilinsky says there are several sectors could be impacted in the current rotation trade environment.
benzinga.com Market Momentum: Your Weekly Financial Forecast Originally published at VolumeLeaders What to expect for July 29- August 02, 2024- benzinga.com These Are The Leveraged ETFs At Play When Trade War Worries Strike
benzinga.com Pharma Catches Another Case Of M&A Fever 
benzinga.com Exploring The Leveraged ETF Trade Heading Into Earnings Season 
benzinga.com As The Market Scrambles Over Tech And Trade Fears, ETF Fund Flow Signals Interesting Rotation 
benzinga.com CUREs For The Ordinary December Trade 
benzinga.com Heaps Of Healthy Health Care ETFs - benzinga.com Which Leveraged ETFs Will Be Hot This Week?
benzinga.com How Volatility Affects 2 Popular Leveraged ETFs - benzinga.com A Conservative Way To Short The S&P 500
- benzinga.com This Biotech ETF Could Be Ready To Party
- benzinga.com Volatility Sparks Inflows To Inverse, Leveraged ETFs
- benzinga.com Leveraged ETF Rebalancing: It's Not As Bad As It Seems
- benzinga.com Wild Ride For Leveraged Biotech ETFs Continues
benzinga.com They're Heeere: Leveraged Cybersecurity ETFs - benzinga.com ProShares Releases 2 New Leveraged Biotech ETFs